“Weight and See”: Initial Weight Gain After Starting Antiretroviral Therapy Is Not Associated With Antiretroviral Regimen Type and Does Not Predict Subsequent Weight Trajectory
In a Canadian cohort with HIV, 61% gained weight, 26% lost weight, and 12% remained stable in the first year of antiretroviral therapy. Weight gain was not associated with regimen type and slowed in years 2 to 3, with 44%, 34%, and 23% experiencing increasing, decreasing, and stable trajectories. Although 23% had significant weight gain year 1, many subsequently lost weight despite continuing antiretroviral therapy.
Authors
- Sharon Walmsley (ORCID: https://orcid.org/0000-0002-3959-5692)
- Leif E. Lovblom (ORCID: https://orcid.org/0000-0002-6774-8924)
- Alice Tseng (ORCID: https://orcid.org/0000-0002-6480-6690)
Institutions
- University Health Network (CA)
- 3M (United States) (US)
- University of Toronto (CA)
- Toronto General Hospital (CA)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1093/ofid/ofae763
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gilead Sciences
- ViiV Healthcare